Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173

Reference

Title : Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors - Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
Author(s) : Grossberg GT , Alva G , Hendrix S , Ellison N , Kane MC , Edwards J
Ref : Alzheimer Disease & Associated Disorders , 32 :173 , 2018
Abstract : Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
ESTHER : Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
PubMedSearch : Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
PubMedID: 29771687

Related information

Citations formats

Grossberg GT, Alva G, Hendrix S, Ellison N, Kane MC, Edwards J (2018)
Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors
Alzheimer Disease & Associated Disorders 32 :173

Grossberg GT, Alva G, Hendrix S, Ellison N, Kane MC, Edwards J (2018)
Alzheimer Disease & Associated Disorders 32 :173